BioNexus Gene Lab Corp (BGLC)
0.5721
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.5721
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2021 | -0.0282M |
| September 30, 2021 | -0.021M |
| June 30, 2021 | -0.0127M |
| March 31, 2021 | -0.0071M |
| December 31, 2020 | -0.0049M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.0807M |
| June 30, 2020 | -0.1815M |
| March 31, 2020 | -0.1836M |
| December 31, 2019 | -0.1808M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.1836M
Minimum
Mar 2020
-0.0049M
Maximum
Dec 2020
-0.0778M
Average
-0.0282M
Median
Dec 2021
Cash from Financing (TTM) Benchmarks
| Balchem Corp | -150.03M |
| Friedman Industries Inc | -4.458M |
| Solitario Resources Corp | 7.57M |
| Golden Minerals Co | 6.799M |
| Paramount Gold Nevada Corp | 11.60M |